Status:
UNKNOWN
Quality of Life and Patient-centered Outcomes After ICU Admission for COVID-19
Lead Sponsor:
Universidade do Porto
Collaborating Sponsors:
Centro Hospitalar De São João, E.P.E.
Centro Hospitalar do Porto
Conditions:
Quality of Life
Long-term Outcomes
Eligibility:
All Genders
18+ years
Brief Summary
Patients suffering from pneumonia due to SARS-CoV-2 infection, after admission to the Intensive Care Unit (ICU), are susceptible to development of various functional sequelae, increased risk of chroni...
Eligibility Criteria
Inclusion
- Men and women aged 18 years and older
- Admission to the intensive care unit (ICU)
- Pneumonia due to proven or suspected SARS-CoV-2 infection
Exclusion
- Refusal to provide consent for the study by the patient or legal guardian
- ICU length of stay less than 24 hours
- Absence of telephone contact
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2022
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT04416464
Start Date
June 15 2020
End Date
October 1 2022
Last Update
September 10 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Hospitalar de Vila Nova de Gaia / Espinho - Unidade I
Vila Nova de Gaia, Porto District, Portugal, 4434-502
2
Centro Hospitalar Universitário de São João
Porto, Portugal
3
Centro Hospitalar Universitário do Porto - Hospital de Santo António
Porto, Portugal